Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors
Sotio Biotech Inc.
Sotio Biotech Inc.
Day One Biopharmaceuticals, Inc.
Palleon Pharmaceuticals, Inc.
Incyte Corporation
Trishula Therapeutics, Inc.
Trishula Therapeutics, Inc.
NGM Biopharmaceuticals, Inc
Aprea Therapeutics
Black Diamond Therapeutics, Inc.
Elevation Oncology
UNC Lineberger Comprehensive Cancer Center
Stanford University
AstraZeneca
VA Office of Research and Development
Eli Lilly and Company
Pfizer
Genentech, Inc.
ADC Therapeutics S.A.
Five Prime Therapeutics, Inc.
Pfizer
pharmaand GmbH
M.D. Anderson Cancer Center
Genmab
Revolution Medicines, Inc.
Ludwig Institute for Cancer Research
Pfizer
Incyte Corporation
Seagen Inc.
EMD Serono
Seagen Inc.
Gilead Sciences
Jerome Canady Research Institute for Advanced Biological & Technological Sciences
Seagen Inc.
Hoffmann-La Roche
Butler Hospital
University of Kansas Medical Center
Beth Israel Deaconess Medical Center
GlaxoSmithKline
Roswell Park Cancer Institute
Amgen
Roswell Park Cancer Institute
Memorial Sloan Kettering Cancer Center
National Institutes of Health Clinical Center (CC)
Fox Chase Cancer Center
Ohio State University Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
Merck Sharp & Dohme LLC
INSYS Therapeutics Inc
Altor BioScience
GlaxoSmithKline